1887

Chapter 9 : Introduction to Prebiotics

Authors: Helena M. R. T. Parracho1, Delphine M. Saulnier2, Anne L. McCartney3, Glenn R. Gibson4
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Department of Food Biosciences, The University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom; 2: Department of Food Biosciences, The University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom; 3: Department of Food Biosciences, The University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom; 4: Department of Food Biosciences, The University of Reading, Whiteknights, Reading, RG6 6AP, United Kingdom
Content Type: Monograph
Publication Year: 2008

Category: Clinical Microbiology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Introduction to Prebiotics, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555815462/9781555814038_Chap09-2.gif

Abstract:

Most of our understanding of the human colonic microbiota is derived from studying the microbial contents of fecal samples, because it is impractical to access the human large intestine during normal digestion, and as an alternative, bacteria detected in feces are most representative of populations present in distal region of the intestine. The colonic microbiota is suggested to play an important role in protection against pathogens and has important trophic effects on intestinal epithelia and immune structure and function. This chapter discusses methods for monitoring the intestinal microbiota, including culture techniques and molecular-based techniques. An alternative approach to probiotics for intestinal microbiota modulation is the use of prebiotics. The best currently recognized prebiotics in Europe are fructooligosaccharides (FOS), galactooligosaccharides (GOS), and lactulose, which (except for lactulose) are legally classified as food or food ingredients. The majority of clinical trials with humans have focused on demonstrating their efficacy in increasing intestinal levels of bifidobacteria and sometimes lactobacilli in fecal samples of healthy subjects. The most documented and recognized effect of prebiotics is the promotion of the growth of beneficial bacteria in the colon.

Citation: Parracho H, Saulnier D, McCartney A, Gibson G. 2008. Introduction to Prebiotics, p 119-130. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch9

Key Concept Ranking

Microbial Ecology
0.45433894
Denaturing Gradient Gel Electrophoresis
0.44443715
0.45433894
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815462.ch09
1. Abrams,, S. A.,, I. J. Griffin,, K. M. Hawthorne,, L. Liang,, S. K. Gunn,, G. Darlington, and, K. J. Ellis. 2005. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 82: 471– 476.
2. Barcenilla,, A.,, S. E. Pryde,, J. C. Martin,, S. H. Duncan,, C. S. Stewart,, C. Henderson, and, H. J. Flint. 2000. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl. Environ. Microbiol. 66: 1654– 1661.
3. Benno, Y.,, K. Sawada, and, T. Mitsuoka. 1984. The intestinal microflora of infants: composition of faecal flora in breast-fed and bottle-fed infants. Microbiol. Immunol. 28: 975– 986.
4. Blaut,, M.,, M. D. Collins,, G. W. Welling,, J. Dore,, J. van Loo, and, W. M. de Vos. 2002. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br. J. Nutr. 2:S203–S211.
5. Bouhnik,, Y.,, K. Vahedi,, L. Achour,, A. Attar,, J. Salfati,, P. Pochart,, P. Marteau,, B. Flourie,, F. Bornet, and, J. C. Ram-baud. 1999. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J. Nutr. 129: 113– 116.
6. Bouhnik,, Y.,, L. Raskine,, G. Simoneau,, E. Vicaut,, C. Neut,, B. Flourie,, F. Brouns, and, F. R. Bornet. 2004. The capacity of nondigestible carbohydrates to stimulate fecal bifido-bacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am. J. Clin. Nutr. 80: 1658– 1664.
7. Buddington,, R. K.,, C. H. Williams,, S. C. Chen, and, S. A. Witherly. 1996. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am. J. Clin. Nutr. 63: 709– 716.
8. Bury-Moné, S.,, S. Skouloubris,, A. Labigne, and, H. De Reuse. 2001. The Helicobacter pylori UreI protein: role in adaptation to acidity and identification of residues essential for its activity and for acid activation. Mol. Microbiol. 42: 1021– 1034.
9. Cherbut, C.,, C. Michel, and, G. Lecannu. 2003. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 133: 21– 27.
10. Collins,, M. D., and, G. R. Gibson. 1999. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69:1052S–1057S.
11. Conly,, J. M.,, K. Stein,, L. Worobetz, and, S. Rutledge-Harding. 1994. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am. J. Gastroenterol. 89: 915– 923.
12. Coudray, C., and, S. J. Fairweather-Tait. 1998. Do oligosaccharides affect the intestinal absorption of calcium in humans? Am. J. Clin. Nutr. 68: 921– 923.
13. Coussement,, P. A. 1999. Inulin and oligofructose: safe intakes and legal status. J. Nutr. 129:S1412–S1417.
14. Cummings,, J. H. 1981. Short chain fatty acids in the human colon. Gut 22: 763– 779.
15. Cummings,, J. H.,, E. W. Pomare,, W. J. Branch,, C. P., E. Naylor, and, G. T. Macfarlane. 1987. Short chain fatty acids in human large intestine, portal hepatic and venous blood. Gut 28: 1221– 1227.
16. Cummings,, J. H.,, S. Christie, and, T. J. Cole. 2001. A study of fructo oligosaccharides in the prevention of travellers’ diarrhoea. Alim. Pharmacol. Ther. 15: 1139– 1145.
17. Cummings,, J. H., and, G. T. Macfarlane. 1991. The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol. 70: 443– 459.
18. Delzenne, N.,, J. Aertssens,, H. Verplaetse,, M. Roccaro, and, M. Roberfroid. 1995. Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat. Life Sci. 57: 1579– 1587.
19. de Vos,, W. M.,, E. Poelwijk,, A. Sessitsch,, E. G. Zoetendal,, L. S. Van-Overbeek, and, A. D. L. Akkermeans. 1997. Molecular approaches for analysing the functionality of probiotic lactic acid bacteria in the gastrointestinal tract, p. 51–57. In Lactic Acid Bacteria. Actes du Colloque LACTIC 1997. Adria Normandie, Villers-Bocage, France.
20. Drasar,, B. S., and, P. A. Barrow. 1985. Intestinal Microbiology. Van Nostrand Reinhold Co Limited, London, United Kingdom.
21. Duineveld, B. M.,, A. S. Rosado,, J. D. van Elsas, and, J. A. van Veen. 1998. Analysis of the dynamics of bacterial communities in the rhizosphere of the chrysanthemum via denaturing gradient gel electrophoresis and substrate utilization patterns. Appl. Environ. Microbiol. 64: 4950– 4957.
22. Eckburg,, P. B.,, E. M. Bik,, C. N. Bernstein,, E. Purdom,, L. Dethlefsen,, M. Sargent,, S. R. Gill,, K. E. Nelson, and, D. A. Relman. 2005. Diversity of the human intestinal microbial flora. Science 308: 1635– 1638.
23. Franks,, A. H.,, H. J. M. Harmsen,, G. C. Raangs,, G. J. Jansen,, F. Schut, and, G. W. Welling. 1998. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligo-nucleotide probes. Appl. Environ. Microbiol. 64: 3336– 3345.
24. Gauhe,, A.,, P. Gyorgy,, J. R. Hoover,, R. Kuhn,, C. S. Rose,, H. W. Ruelis, and, F. Zilliken. 1954. Bifidus factor-preparation obtained from human milk. Arch. Biochem. 49: 214– 224.
25. Gibson,, G. R. 1998. Dietary modulation of the human gut microflora using probiotics. Br. J. Nutr. 80:S209–S212.
26. Gibson,, G. R.,, and M. D. Collins. 1999. Concept of balanced colonic microbiota, prebiotics, and synbiotics, p. 139–152. In L. A. Hanson and, R. H. Yolken (ed.), Probiotics, Other Nutritional Factors, and Intestinal Microflora, vol. 42. Nestec Ltd, Vevey/Lippincott-Raven Publishers, Philadelphia, PA.
27. Gibson, G. R., and, A. L. McCartney. 1998. Modification of the gut flora by dietary means. Biochem. Soc. Trans. 26: 222– 228.
28. Gibson, G. R., and, R. A. Rastall (ed.). 2006. Prebiotics: Development and Application. John Wiley & Sons Ltd., Chichester, United Kingdom.
29. Gibson, G. R., and, M. B. Roberfroid. 1995. Dietary modulation of the human colonic microflora introducing the concept of probiotics. J. Nutr. 125: 1401– 1412.
30. Gibson,, G. R., and, M. B. Roberfroid (ed.). 1999. Colonic Microbiota, Nutrition and Health. Kluwer Academic Publishers, Dordrecht, The Netherlands.
31. Gibson, G. R., and, X. Wang. 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 77: 412– 420.
32. Gibson,, G. R.,, E. R. Beatty,, X. Wang, and, J. H. Cummings. 1995. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108: 975– 982.
33. Gibson,, G. R.,, P. B. Ottaway, and, R. A. Rastall. 2000. The gut microflora and its modulation through diet, p. 7–9. In Probiotics: New Developments in Functional Foods. Chadwick House Group, Chandos Publishing Ltd., London, United Kingdom.
34. Gibson,, G. R.,, H. M. Probert,, J. A. E. van Loo,, R. A. Rastall, and, M. B. Roberfroid. 2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17: 259– 275.
35. Gmeiner,, M.,, W. Kneifel,, K. D. Kulbe,, R. Wouters,, P. de Boever,, L. Nollet, and, W. Verstraete. 2000. Influence of a synbiotic mixture consisting of Lactobacillus acidophilus 74–2 and a fructooligosaccharide preparation on the microbial ecology sustained in a simulation of the human intestinal microbial ecosystem (SHIME reactor). Appl. Microbiol. Biotechol. 53: 219– 233.
36. Guarner, F. 2006. Enteric flora in health and disease. Digestion 73: 5– 12.
37. Guarner, F., and, J.-R. Malagelada. 2003. Gut flora in health and disease. Lancet 361: 512– 519.
38. Harmsen,, H. J. M.,, P. Elfferich,, F. Schut, and, G. W. Welling. 1999. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridisation. Microbiol. Ecol. Health Dis. 11: 3– 12.
39. Harmsen,, H. J. M.,, A. C. M. Wildeboer-Veloo,, J. Grijpstra,, J. Knol,, J. E. Degener, and, G. W. Welling. 2000. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl. Environ. Microbiol. 66: 4523– 4527.
40. Holzapfel,, W. H.,, P. Haberer,, J. Snel,, U. Schillinger, and, J. H. Huis isn’t Veld. 1998. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85– 101.
41. Hopkins,, M. J.,, R. Sharp, and, G. T. Macfarlane. 2001. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85– 101.
42. Imamura, L.,, K. Hisamitsu, and, K. Kobashi. 1994. Purification and characterization of β-fructofuranosidase from Bifidobacterium infantis. Biol. Pharm. Bull. 17: 596– 602.
43. Kimura, K.,, A. L. McCartney,, M. A. McConnell, and, G. W. Tannock. 1997. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl. Environ. Microbiol. 63: 3394– 3398.
44. Kleessen, B.,, B. Sykura,, H. J. Zunft, and, M. Blaut. 1997. Effects of inulin and lactose on faecal microflora, microbial activity and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 65: 1397– 1402.
45. Kruse,, H. P.,, B. Kleessen, and, M. Blaut. 1999. Effects of inulin on faecal bifidobacteria in human subjects. Br. J. Nutr. 82: 375– 382.
46. Kunz,, C.,, S. Rudloff,, W. Baier,, N. Klein,, and S. Strobel. 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Ann. Rev. Nutr. 20: 699– 722.
47. Lambert, J., and, R. Hull. 1996. Upper gastrointestinal disease and probiotics. Asia Pac. J. Clin. Nutr. 5: 31– 35.
48. Langendijk,, P.,, F. Schut,, G. Jansen,, G. C. Raangs,, G. R. Kamphuis,, M. H. Wilkinson, and, G. W. Welling. 1995. Quantitative fluorescent in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl. Environ. Microbiol. 61: 3069– 3075.
49. Langlands,, S. J.,, M. J. Hopkins,, N. Coleman, and, J. H. Cummings. 2005. Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel. Gut 53: 1610– 1616.
50. Levitt,, M. D., and, J. H. Bond. 1970. Volume, composition and source of intestinal gas. Gastroenterology 59: 921– 929.
51. Lewis, S.,, S. Burmeister, and, J. Brazier. 2005a. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin. Gastroenterol. Hepatol. 3: 442– 448.
52. Lewis, S.,, S. Burmeister,, S. Cohen,, J. Brazier, and, A. Awasthi. 2005b. Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 21: 469– 477.
53. Macfarlane,, G. T., and, A. J. McBain. 1999. The human colonic microbiota, p. 1–25. In G. R. Gibson and, M. B. Roberfroid (ed.), Colonic Microbiota, Nutrition and Health. Kluwer Academic Publishers, Dordrecht, The Netherlands.
54. Macfarlane, S.,, G. T. Macfarlane, and, J. H. Cummings. 2006. Review article: prebiotics in the gastrointestinal tract. Aliment. Pharmacol. Ther. 24: 701– 714.
55. Manz, W.,, R. Amann,, W. Ludwig,, M. Vancanneyt, and, K. H. Schleifer. 1996. Application of a suite of 16S rRNAspecific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142: 1097– 1106.
56. McCartney,, A. L. 2002. Application of molecular biological methods for studying probiotics and the gut flora. Br. J. Nutr. 88:S29–S37.
57. McCartney,, A. L., and, G. R. Gibson. 1998. The application of prebiotics in human health and nutrition, p. 59–73. In Proceedings Lactic 97. Which Strains? For Which Products? Adria Normandie, Villers-Bocage, France.
58. Menne, E.,, N. Guggenbuhl, and, M. Roberfroid. 2000. Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. J. Nutr. 130: 1197– 1199.
59. Metchnikoff, E. 1907. The Prolongation of Life. William Heineman, London, United Kingdom.
60. Mitsuoka, T. 1992. Intestinal flora and aging. Nutr. Rev. 50: 438– 446.
61. Moore,, W. E. C.,, E. P. Cato, and, L. V. Holdeman. 1978. Some current concepts in intestinal bacteriology. Am. J. Clin. Nutr. 31:S33–S42.
62. Moore, W. E. C., and, L. V. Holdeman. 1974. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl. Environ. Microbiol. 27: 961– 979.
63. Moro,, G.,, I. Minoli,, M. Mosca,, S. Fanaro,, J. Jelinek,, B. Stahl, and, G. Boehm. 2002. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J. Pediatr. Gastroenterol. Nutr. 34: 291– 295.
64. Mountzouris,, K. C.,, A. L. McCartney, and, G. R. Gibson. 2002. Intestinal microflora of human infants and current trends for its nutritional modulation. Br. J. Nutr. 87: 405– 420.
65. Muyzer, G., and, E. C. D. Waal. 1993. Profiling of complex microbial populations by denaturing grading gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 59: 695– 700.
66. Mykkanen, H.,, K. Laiho, and, S. Salminen. 1998. Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J. Appl. Microbiol. 85: 37– 41.
67. O’Sullivan,, D. J. 2000. Methods for analysis of the intestinal microflora. Curr. Issues. Intest. Microbiol. 1: 39– 50.
68. Petschow,, B. W., and, R. D. Talbott. 1991. Response of Bifidobacterium species to growth promoters in human and cow milk. Pediatr. Res. 29: 208– 213.
69. Playne,, M. J.,, L. E. Bennett, and, G. W. Smithers. 2003. Functional dairy foods and ingredients. Austr. J. Dairy Technol. 58: 242– 264.
70. Playne,, M. J., and, R. Crittenden. 1996. Commercially available oligosaccharides. Bull. Int. Dairy Found. 313: 10– 22.
71. Pool-Zobel,, B. L. 2005. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br. J. Nutr. 93:S73–S90.
72. Probert,, H. M., and, G. R. Gibson. 2002. Investigating the pre-biotic and gas-generating effects of selected carbohydrates on the human colonic microflora. Lett. Appl. Microbiol. 35: 473– 480.
73. Reddy,, B. S. 1998. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br. J. Nutr. 80:S219–S223.
74. Reddy,, B. S. 1999. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J. Nutr. 129:1478S–1482S.
75. Roberfroid,, M. B.,, J. Cumps, and, J. P. Devogelaer. 2002. Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J. Nutr. 132: 3599– 3602.
76. Rotimi,, V. O., and, B. I. Duerden. 1981. The development of the bacterial flora in normal neonates. J. Med. Microbiol. 14: 51– 62.
77. Rowland,, I. R.,, C. J. Rumney,, J. T. Coutts, and, L. C. Lievense. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281– 285.
78. Rycroft,, C. E.,, L. J. Fooks, and, G. R. Gibson. 1999. Methods for assessing the potential of prebiotics and probiotics. Curr. Opin. Clin. Nutr. Metab. Care 2: 1– 4.
79. Salminen,, S.,, C. Bouley,, M. C. Boutron-Ruault,, J. H. Cummings,, A. Franck,, G. R. Gibson,, E. Isolauri,, M. C. Moreau,, M. Roberfroid, and, I. Rowland. 1998. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80:S147–S171.
80. Scholz-Ahrens,, K. E.,, G. Schaafsma,, E. van den Heuvel, and, J. Schrezenmeir. 2001. Effects of prebiotics on mineral metabolism. Am. J. Clin. Nutr. 73:459S–464S.
81. Sighir, A.,, J. Doré, and, R. I. Mackie. 1999. Molecular diversity and phylogeny of human colonic bacteria. Molecular Ecology in Gastrointestinal Systems. New Frontiers: Proceedings of the 8th International Symposium on Microbial Ecology, Halifax, Canada.
82. Smith,, E. A., and, G. T. Macfarlane. 1996. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention on dissimilatory aromatic amino acid metabolism. J. Appl. Bacteriol. 81: 288– 302.
83. Stark,, P. L., and, A. Lee. 1982. The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J. Med. Microbiol. 15: 189– 203.
84. Steer, T.,, H. Carpenter,, K. Tuohy, and, G. R. Gibson. 2001. Perspectives on the role of the human gut microflora in health and disease and its modulation by pro- and prebiotics. Nutr. Res. Rev. 13: 229– 254.
85. Tahiri,, M.,, J. C. Tressol,, Y. Arnaud,, F. R., J. Bornet,, C. Bouteloup-Demange,, C. Feillet-Coudray,, M. Brandolini,, V. Ducros,, D. Pepin,, F. Brouns,, A. M. Roussel,, Y. Rayssiguier, and, C. Coudray. 2003. Effect of short-chain fructooligosaccharides on intestinal calcium absorption and calcium status in postmenopausal women: a stable-isotope study. Am. J. Clin. Nutr. 77: 449– 457.
86. Tancrède, C. 1992. Role of human microflora in health and disease. Eur. J. Clin. Microbiol. Infect. Dis. 11: 1012– 1015.
87. Tannock,, G. W. 1999. A fresh look at the intestinal micro-flora, p. 5–12. In G. W. Tannock (ed.), Probiotics: a Critical Review. Horizon Scientific Press, Wymondham, United Kingdom.
88. Tannock,, G. W.,, K. Munro,, H. J. M Harmsen,, G. W. Welling,, J. Smart, and, P. K. Gopal. 2000. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 66: 2578– 2588.
89. Teuri, U.,, R. Korpela,, M. Saxelin,, L. Montonen, and, S. Salminen. 1998. Increased fecal frequency and gastrointestinal symptoms following ingestion of galacto-oligosaccharide-containing yogurt. J. Nutr. Sci. Vitaminol. 44: 465– 471.
90. Tuohy,, K. M.,, H. M. Probert,, C. W. Smeijkal, and, G. R. Gibson. 2003. Using probiotics and prebiotics to improve gut health. Ther. Focus 8: 692– 700.
91. van den Heuvel,, E. G.,, M. H. Schoterman, and, T. Muijs. 2000. Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J. Nutr. 130: 2938– 2942.
92. van der Waaij, D. 1999. Microbial ecology of the intestinal microflora: influence of interactions with the host organism, p. 1–16. In L. A. Hanson and, R. H. Yolken (ed.), Probiotics, Other Nutritional Factors, and Intestinal Microflora, vol. 42. Nestec Ltd, Vevey/Lippincott-Raven Publishers, Philadelphia, PA.
93. Vaughan, E. E.,, F. Schut,, H. G. J. Heilig,, E. G. Zoetendal,, W. M. de Vos, and, A. D. L. Akkermans. 2000. A molecular view of the intestinal ecosystem. Curr. Issues Intest. Microbiol. 1: 1– 12.
94. Videla, S. 1999. Deranged luminal pH homeostasis in experimental colitis can be restored by a prebiotic. Gastroenterology 116:A942.
95. Videla,, S.,, J. Vilaseca,, M. Antolin,, A. Garcia-Lafuente,, F. Guarner,, E. Crespo,, J. Casalots,, A. Salas, and, J. R. Malagelada. 2001. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am. J. Gastroenterol. 96: 1486– 1493.
96. Wang, X., and, G. R. Gibson. 1993. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacteriol. 75: 373– 380.
97. Welters,, C. F.,, E. Heineman,, F. B. Thunnissen,, A. E. van den Bogaard,, P. B. Soeters, and, C. G. Baeten. 2002. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis. Colon Rectum 45: 621– 627.
98. Williams,, C. H.,, S. A. Witherly, and, R. K. Buddington. 1994. Influence of dietary neosugar on selected bacterial groups of the human fecal microb. Microb. Ecol. Health Dis. 7: 91– 97.
99. Wilson,, K. H., and, R. B. Blitchington. 1996. Human colonic biota studied by ribosomal DNA sequence analysis. Appl. Environ. Microbiol. 62: 2273– 2278.
100. Woese,, C. R. 1987. Bacterial evolution. Microbiol. Rev. 51: 221– 271.
101. Zheng, D.,, E. W. Alm,, D. A. Stahl, and, L. Raskin. 1997. Characterization of universal small-subunit rRNA hybridization probes for quantitative molecular microbial ecology studies. Appl. Environ. Microbiol. 62: 4505– 4513.
102. Zoetendal,, E. G.,, A. D. L. Akkermans,, D. M. Akkermans-van Vilet,, J. A., G. M. De Visser, and, W. M. De Vos. 2001. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb. Ecol. Health Dis. 13: 129– 134.
103. Zopf, D., and, S. Roth. 1996. Oligosaccharide anti-infective agents. Lancet 347: 1017– 1021.

Tables

Introduction to Prebiotics
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch09-1,webId=/content/author/10.1128/9781555815462.ch09-1,properties={foaf_givenname=Helena M. R. T., foaf_name=Helena M. R. T. Parracho, foaf_surname=Parracho, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch09-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch09-2,webId=/content/author/10.1128/9781555815462.ch09-2,properties={foaf_givenname=Delphine M., foaf_name=Delphine M. Saulnier, foaf_surname=Saulnier, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch09-aff2]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch09-3,webId=/content/author/10.1128/9781555815462.ch09-3,properties={foaf_givenname=Anne L., foaf_name=Anne L. McCartney, foaf_surname=McCartney, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch09-aff3]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815462.ch09-4,webId=/content/author/10.1128/9781555815462.ch09-4,properties={foaf_givenname=Glenn R., foaf_name=Glenn R. Gibson, foaf_surname=Gibson, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555815462.ch09-aff4]]}]]
Citation: Parracho H, Saulnier D, McCartney A, Gibson G. 2008. Introduction to Prebiotics, p 119-130. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch9
/content/10.1128/9781555815462.ch09.ch09table01
Table 1
Human studies designed to determine the prebiotic effects of FOS and GOS
Generic image for table
Table 1

Human studies designed to determine the prebiotic effects of FOS and GOS

Citation: Parracho H, Saulnier D, McCartney A, Gibson G. 2008. Introduction to Prebiotics, p 119-130. In Versalovic J, Wilson M (ed), Therapeutic Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555815462.ch9

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error